FXR induces SOCS3 and suppresses hepatocellular carcinoma

Fei Guo1, Zhizhen Xu2, Yan Zhang2

  • 1Department of Hepatobiliary Surgery Institute, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.

Oncotarget
|September 30, 2015
PubMed

Insights

Farnesoid X Receptor (FXR) activation inhibits liver cancer growth by increasing Suppressor of cytokine signaling 3 (SOCS3). This FXR-SOCS3 pathway offers a new target for hepatocellular carcinoma (HCC) prevention and treatment.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Oncology

Background:

  • Suppressor of cytokine signaling 3 (SOCS3) inhibits liver carcinogenesis via STAT3 signaling.
  • Farnesoid X Receptor (FXR) protects against hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To investigate if FXR's tumor-suppressive activity involves SOCS3 regulation.
  • To elucidate the molecular mechanism of FXR in HCC.

Main Methods:

  • FXR activation using GW4064 in HCC cells.
  • SOCS3 knockdown via siRNA.
  • Reporter assays, EMSA, and ChIP assays.
  • In vivo HCC xenograft studies in nude mice.

Main Results:

  • FXR activation inhibited HCC cell growth, induced G1 cell cycle arrest, and repressed STAT3 activity.
  • FXR enhanced SOCS3 promoter activity, directly binding to its promoter region.
  • FXR activation up-regulated SOCS3 and p21 expression, inhibiting STAT3 phosphorylation in vivo.

Conclusions:

  • FXR exerts anti-HCC effects through SOCS3 induction.
  • The FXR-SOCS3 signaling pathway is a potential therapeutic target for HCC.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
44.1K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
7.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
5.9K